You’ve done the math. Branded Wegovy at retail is pushing $1,300 a month. Your insurance denies it. You’re not interested in a year-long coaching program you didn’t ask for. You want a licensed physician, a real pharmacy, and a price that doesn’t require a payment plan. That’s the situation a lot of people are actually in right now, and it’s why compounded semaglutide providers are still drawing serious attention even after the FDA sent warning letters to 30-plus telehealth companies in early 2026.
The picks below are based on what keeps coming up in patient forums, cost comparisons, and pharmacy transparency discussions. No single option wins for everyone.
1. HealthRX
For pure price-to-access value, this one is hard to argue with. Compounded semaglutide starts at $99 per month and compounded tirzepatide at $149, which undercuts most telehealth competitors by a meaningful margin. What separates it from the cheaper end of the market is the pharmacy chain behind it. Medication ships from Manifest Pharmacy in Greer, South Carolina, a 503A/USP-797 accredited facility that lot-tracks every vial from bench to delivery. That’s specific and verifiable, which matters when so many providers quietly decline to name their compounding lab.
The workflow is straightforward. You fill out a health assessment online, a board-certified U.S. physician reviews it within roughly 24 hours, and the medication ships overnight at no extra charge to all 50 states. HealthRX also carries LegitScript certification (certificate 50087439), a third-party compliance check that not every telehealth brand bothers to obtain. The trial data the brand points to is from published studies, SURMOUNT-1 for tirzepatide (~21% body weight at 72 weeks) and STEP 1 for semaglutide (~15% at 68 weeks), not internal claims. Fair presentation of third-party evidence is more trustworthy than vague before-and-after language.
Compounded medications are not FDA-approved. That applies here as everywhere else on this list.
2. Mochi Health
Mochi is the pick when you want more medical oversight baked into the monthly fee. Board-certified obesity-medicine clinicians, not just general practitioners, review your case. Monthly pricing lands near $99 for compounded semaglutide and $199 for tirzepatide. The monitoring cadence is heavier than most cash-pay options, which suits people who want ongoing clinical contact and aren’t just looking for a prescription and a tracking app.
3. FormBlends
FormBlends earns its spot for a different reason than price. It’s a compounded GLP-1 telehealth option with physician oversight and dispensing through an FDA-registered 503A pharmacy, but the thing that genuinely sets it apart is published per-product lab testing. HPLC purity percentages, mass spectrometry identity confirmation, endotoxin and sterility results. Named numbers, not just a claim of quality assurance. That level of transparency is uncommon in this space.
Semaglutide runs around $299 per vial and tirzepatide around $349, so the pricing is higher than HealthRX’s entry point. Ships to 47 states, not 50. The trade-off is clear: if seeing the actual purity data before injecting something matters more to you than hitting the lowest monthly rate, FormBlends is the logical choice. It also carries a broader peptide catalog covering recovery, longevity, and cognitive support under the same clinician model, which is genuinely unusual for a GLP-1-focused provider. One provider relationship, wider scope.
4. Henry Meds
Henry Meds is a cash-pay, no-insurance-required operation with a reputation for fast fulfillment, typically 24 to 72 hours after approval. First-month pricing often comes in between $179 and $249. The monitoring is lighter than Mochi, which is a fair trade-off for people who’ve already done the homework, have a primary care physician they see separately, and just want access to medication without friction. No contracts.
5. Eden
Eden charges around $149 per month for compounded semaglutide, positions itself as a straightforward cash-pay option, and doesn’t bury the pricing. The platform is relatively simple. It won’t suit someone who wants a dietitian or intensive check-ins, but for a self-directed person who wants a clean, low-cost pathway with physician sign-off, it covers the basics without extras that drive up cost.
A Few Things to Keep in Mind
The March 2026 Novo Nordisk settlement pushed several large brands, including Hims and Hers, away from compounded GLP-1s entirely toward branded medications. The compounded market is still active but under regulatory scrutiny. Anyone considering compounded semaglutide should confirm their provider uses a named, inspectable 503A pharmacy, not a private-label arrangement with no traceable origin. These medications are not FDA-approved equivalents of Ozempic or Wegovy. Talk to a doctor you trust before starting, especially if you have any cardiovascular or gastrointestinal history.
Common Questions
Does HealthRX’s $99 price actually include the medication, or is that just the consultation fee?
The $99 per month figure covers the compounded semaglutide itself, not just the provider visit. Overnight shipping is also included at no extra charge. That said, pricing can change, so confirm the current all-in cost directly with HealthRX before completing your intake form, since telehealth platforms adjust rates without much notice.
What does it actually mean that FormBlends publishes HPLC and mass spectrometry results?
It means a third-party lab ran quantitative tests confirming the active ingredient is present at the stated concentration and that no major impurities showed up. HPLC measures purity as a percentage. Mass spectrometry confirms molecular identity. Most compounding providers claim quality assurance without publishing the underlying numbers, so FormBlends showing those figures is a meaningful difference, not just marketing language.
Can Mochi Health prescribe to people who have never used a GLP-1 before, or is it mainly for people switching from Ozempic or Wegovy?
Mochi’s obesity-medicine clinicians evaluate new patients, not just people transitioning off branded medications. If you have no prior GLP-1 history, you can still go through their intake process. The heavier monitoring cadence they offer is arguably more useful for first-time users who want clinical guidance through dose titration rather than self-managing a new medication entirely alone.
Why does FormBlends only ship to 47 states while HealthRX ships to all 50?
Compounding pharmacies face state-level licensing and pharmacy board rules that vary across the country. A 503A facility is not automatically permitted to ship into every state, and some states impose stricter requirements on out-of-state compounded drug shipments. FormBlends has not publicly named which three states it excludes, so check directly if you are in a less-populous state before starting an intake.
After the March 2026 Novo Nordisk settlement, are any of these providers at legal risk of being forced to stop offering compounded semaglutide?
The settlement primarily affected large platforms like Hims and Hers that had specific arrangements with Novo Nordisk. Compounded semaglutide from 503A pharmacies remains legal when the branded drug is on the FDA shortage list or when a physician determines a patient has a documented clinical need for a customized formulation. The regulatory picture is shifting, and providers can lose access if shortage status changes, so this is worth monitoring before committing to a multi-month plan.
Sources
- FDA: 503A Compounding Pharmacy Oversight, fda.gov
- STEP 1 Trial (Wilding et al., NEJM 2021): semaglutide weight outcomes
- SURMOUNT-1 Trial (Jastreboff et al., NEJM 2022): tirzepatide weight outcomes
- LegitScript Healthcare Merchant Certification Program, legitscript.com
- Novo Nordisk compounding settlement reporting, Reuters / STAT News (March 2026)
